Characterizing diabetic cardiomyopathy: baseline results from the ARISE-HF trial

Characterizing diabetic cardiomyopathy: baseline results from the ARISE-HF trial

Abstract Background Diabetic cardiomyopathy (DbCM) is a form of Stage B heart failure (HF) at high risk for progression to overt disease. Using baseline characteristics of study participants from the Aldose Reductase Inhibition for Stabilization of Exercise Capacity in Heart Failure (ARISE-HF) Trial...

Full description

Bibliographic Details
Main Authors: James L. Januzzi, Stefano Del Prato, Julio Rosenstock, Javed Butler, Justin Ezekowitz, Nasrien E. Ibrahim, Carolyn S.P. Lam, Thomas Marwick, W. H. Wilson Tang, Yuxi Liu, Reza Mohebi, Alessia Urbinati, Faiez Zannad, Riccardo Perfetti
Format: Article
Language:English
Published: BMC 2024-02-01
Series:Cardiovascular Diabetology
Subjects:
Diabetes
Cardiomyopathy
Heart failure
Online Access:https://doi.org/10.1186/s12933-024-02135-z

Internet

https://doi.org/10.1186/s12933-024-02135-z

Similar Items